首页> BMC cancer> Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study.

Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study.

导出 OA

翻译打印收藏纠错

第一作者： Lucas E,Flausino

第一单位： Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.;Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, Brazil.

作者： Lucas E,Flausino ^[1] ; Alexis Germán Murillo,Carrasco ^[1] ; Tatiane Katsue,Furuya ^[1] ; Wen-Jan,Tuan ^[2] ; Roger,Chammas ^[3]

作者单位： Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.;Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, Brazil. ^[1] Department of Family and Community Medicine, and Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA. ^[2] Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. rchammas@usp.br.;Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, Brazil. rchammas@usp.br. ^[3]

关键词 Cancer treatment Chemotherapy Gastrointestinal cancer Multicenter collaborative network study Radiotherapy Sodium-glucose co-transporter 2 inhibitor (SGLT2i)